Amnis Therapeutics is an Israeli bio-med engineering company, specializes in developing, manufacturing and marketing of lifesaving endovascular technologies for emergency situations. The company’s portfolio and future pipeline of products focus on biocompatible minimally invasive devices addressing unmet needs in interventional cardiology and neuroradiology. Our mission is to provide the medical community with innovative, high-performance devices that offer a reliable, proven solution for numerous endovascular indications. Amnis has a well-established worldwide distribution network, generating recurrent sales.